SCUBE2 and breast carcinoma: This observation is consistent with previous studies indicating that SCUBE2 expression is associated with chemotherapy resistance and may influence clinical outcomes in breast cancer[38, 39] Pathway enrichment analysis further revealed that these gene expression differences were associated with immune‐related biological processes, including immune response regulation, antigen presentation, and cell adhesion.